Skip to content
My WebMD Sign In, Sign Up

Brain Cancer Health Center

Medical Reference Related to Brain Cancer

  1. Changes to This Summary (07 / 27 / 2012)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Stage Information for Pituitary TumorsUpdated staging information for 2010 (cited Edge et al. as reference 1).This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

  2. Get More Information From NCI

    This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information on Adult Brain Tumors treatment.

  3. Treatment of Low-Risk Neuroblastoma

    In North America,the Children’s Oncology Group (COG) is investigating a risk-based neuroblastoma treatment plan that assigns all patients to low-,intermediate-,and high-risk groups based on age,International Neuroblastoma Staging System (INSS) stage,and tumor biology (i.e.,MYCN gene amplification,Shimada classification,and DNA ploidy).[ 1 ] (Risk groups are defined in Table 1 of the Stage ...

  4. General Information

    The National Cancer Institute provides the PDQ pediatric cancer treatment information summaries as a public service to increase the availability of evidence-based cancer information to health professionals,patients,and the public. In recent decades,dramatic improvements in survival have been achieved for children and adolescents with cancer. Childhood and adolescent cancer survivors require ...

  5. Cellular Classification of Pituitary Tumors

    Pituitary adenomas can be classified according to staining affinities of the cell cytoplasm, size, endocrine activity, histologic characteristics, hormone production and contents, ultrastructural features, granularity of the cell cytoplasm, cellular composition, cytogenesis, and growth pattern.[1] Recent classifications, however, omit criteria based on tinctorial stains (i.e., acidophilic, basophilic, and chromophobic) because of the poor correlation between staining affinities of the cell cytoplasm and other pathological features of pituitary tumors, such as the type of hormone produced and cellular derivation.[1,2]A unifying pituitary adenoma classification incorporates the histological, immunocytochemical, and electron microscopic studies of the tumor cells, and stresses the importance of hormone production, cellular composition, and cytogenesis. This classification emphasizes the structure-function relationship and attempts to correlate morphologic features with secretory

  6. nci_ncicdr0000062843-nci-header

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Childhood Ependymoma Treatment

  7. Treatment of Recurrent Childhood Low-Grade Astrocytomas

    Childhood low-grade astrocytomas may recur many years after initial treatment. Recurrent disease is usually at the primary tumor site, although multifocal or widely disseminated disease to other intracranial sites and to the spinal leptomeninges has been documented.[1,2] Most children whose low-grade fibrillary astrocytomas recur will harbor low-grade lesions; however, malignant transformation is possible.[3]At the time of recurrence, a complete evaluation to determine the extent of the relapse is indicated. Biopsy or surgical resection may be necessary for confirmation of relapse because other entities, such as secondary tumor and treatment-related brain necrosis, may be clinically indistinguishable from tumor recurrence. The need for surgical intervention must be individualized on the basis of the initial tumor type, the length of time between initial treatment and the reappearance of the mass lesion, and the clinical picture. An individual plan needs to be tailored based on patient

  8. Neuroblastoma Screening

    Neuroblastoma is a cancer that primarily affects children. It begins in nerve tissue in the neck,chest,abdomen,or pelvis. It usually originates in the abdomen in the tissues of the adrenal gland. By the time it is diagnosed,the cancer often has spread,most commonly to the lymph nodes,liver,lungs,bones,and/or bone marrow. Risk of neuroblastoma Neuroblastoma is the most common type of ...

  9. Significance

    Incidence and Mortality About 7% of all malignancies in children under the age of 15 are neuroblastomas. About one quarter of cancers in the first year of life are neuroblastomas,making this the most frequent histological type of infant cancer.[ 1,2 ] The incidence rate of the disease in children younger than 1 year is about 35 per million but declines rapidly with age to about 1 per million ...

  10. General Information

    This cancer treatment information summary provides an overview of the diagnosis,classification,treatment,and prognosis of childhood brain stem gliomas. The National Cancer Institute provides the PDQ pediatric cancer treatment information summaries as a public service to increase the availability of evidence-based cancer information to health professionals,patients,and the public. These ...

Displaying 11 - 20 of 154 Articles << Prev Page 1 2 3 4 5 6 7 8 9 10 Next >>

Today on WebMD

human brain xray
Article
Computed Tomography CT Scan Of The Head
Article
 
Integrative Medicine Cancer Quiz
Article
what is your cancer risk
Health Check
 

Malignant Gliomas
Article
Pets Improve Your Health
SLIDESHOW
 
Headache Emergencies
Video
life after a brain tumor
VIDEO
 

Would you consider trying alternative or complementary therapies?


WebMD Special Sections